AI assistant
Sending…
Salarius Pharmaceuticals, Inc. — Director's Dealing 2016
Mar 8, 2016
35494_dirs_2016-03-08_d46acb03-9c69-4a1b-94ea-a2db61914396.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Flex Pharma, Inc. (FLKS)
CIK: 0001615219
Period of Report: 2016-03-05
Reporting Person: Stacy Michelle (Director)
More from Salarius Pharmaceuticals, Inc.
Regulatory Filings
2026
May 19
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 2
Regulatory Filings
2026
Apr 2
Declaration of Voting Results & Voting Rights Announcements
2026
Feb 25
Major Shareholding Notification
2026
Feb 17
Proxy Solicitation & Information Statement
2026
Jan 9
Regulatory Filings
2026
Jan 8
Delisting Announcement
2026
Jan 2
Director's Dealing
2026
Jan 2